Does REACH provide sufficient information to regulate mutagenic and carcinogenic substances?
暂无分享,去创建一个
Marjolijn Woutersen | Martijn Beekman | Marja E. J. Pronk | Andre Muller | Joop A. de Knecht | Betty C. Hakkert | M. Woutersen | B. Hakkert | J. D. de Knecht | A. Muller | M. Pronk | M. Beekman
[1] Sven Ove Hansson,et al. Registration, Evaluation, and Authorization of Chemicals (REACH) Is but the First Step–How Far Will It Take Us? Six Further Steps to Improve the European Chemicals Legislation , 2009, Environmental health perspectives.
[2] Corvi Raffaella,et al. Analysis of carcinogenicity testing for regulatory purposes in the European Union , 2016 .
[3] H. Foth,et al. Background of REACH in EU regulations on evaluation of chemicals , 2008, Human & experimental toxicology.
[4] S. Viegas. A “nova” Directiva Comunitária 2004/37/EC sobre Agentes Carcinogénicos e Mutagénicos: The “new” Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work , 2018 .
[5] D. Paustenbach,et al. The European Union’s REACH regulation: a review of its history and requirements , 2009, Critical reviews in toxicology.